End-of-day quote
Nyse
18:00:00 2024-05-01 EDT
|
5-day change
|
1st Jan Change
|
57.18
USD
|
+3.03%
|
|
+1.49%
|
+3.16%
|
Fiscal Period: September |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
817.7
|
1,215
|
2,808
|
5,420
|
7,521
|
-
|
-
|
Enterprise Value (EV)
1 |
1,455
|
1,660
|
3,702
|
6,228
|
8,294
|
8,237
|
8,100
|
P/E ratio
|
34.6
x
|
43.9
x
|
23.4
x
|
33.5
x
|
36.5
x
|
30
x
|
24.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.83
x
|
0.97
x
|
2.05
x
|
3.25
x
|
3.91
x
|
3.52
x
|
3.12
x
|
EV / Revenue
|
1.47
x
|
1.33
x
|
2.7
x
|
3.74
x
|
4.31
x
|
3.85
x
|
3.36
x
|
EV / EBITDA
|
7.38
x
|
7.1
x
|
13.6
x
|
18.4
x
|
21.1
x
|
18.9
x
|
16.1
x
|
EV / FCF
|
15.3
x
|
7.39
x
|
193
x
|
29.1
x
|
40.5
x
|
30.7
x
|
25.7
x
|
FCF Yield
|
6.53%
|
13.5%
|
0.52%
|
3.43%
|
2.47%
|
3.25%
|
3.88%
|
Price to Book
|
-5.09
x
|
-64.3
x
|
-7.41
x
|
-16.7
x
|
-29.4
x
|
-42.6
x
|
82
x
|
Nbr of stocks (in thousands)
|
39,429
|
39,510
|
136,244
|
131,446
|
130,979
|
-
|
-
|
Reference price
2 |
20.74
|
30.75
|
20.61
|
41.23
|
57.42
|
57.42
|
57.42
|
Announcement Date
|
20-11-19
|
21-11-18
|
22-11-17
|
23-11-20
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
854.4
|
988.3
|
1,247
|
1,372
|
1,667
|
1,923
|
2,138
|
2,410
|
EBITDA
1 |
198.1
|
197.2
|
233.9
|
271.4
|
338.3
|
393.3
|
435.6
|
502.8
|
EBIT
1 |
169.2
|
165.4
|
172.9
|
239.1
|
295.5
|
346.9
|
391.8
|
460
|
Operating Margin
|
19.8%
|
16.74%
|
13.86%
|
17.43%
|
17.73%
|
18.04%
|
18.33%
|
19.09%
|
Earnings before Tax (EBT)
1 |
162.5
|
109.3
|
123.2
|
145.6
|
220.4
|
277.9
|
332
|
376.2
|
Net income
1 |
123.1
|
23.5
|
27.6
|
82.3
|
165.5
|
208.1
|
250.7
|
284
|
Net margin
|
14.41%
|
2.38%
|
2.21%
|
6%
|
9.93%
|
10.82%
|
11.73%
|
11.79%
|
EPS
2 |
3.120
|
0.6000
|
0.7000
|
0.8800
|
1.230
|
1.574
|
1.912
|
2.320
|
Free Cash Flow
1 |
95.1
|
95.1
|
224.5
|
19.2
|
213.8
|
205
|
268
|
314.7
|
FCF margin
|
11.13%
|
9.62%
|
18%
|
1.4%
|
12.83%
|
10.66%
|
12.54%
|
13.06%
|
FCF Conversion (EBITDA)
|
48.01%
|
48.23%
|
95.98%
|
7.07%
|
63.2%
|
52.12%
|
61.52%
|
62.59%
|
FCF Conversion (Net income)
|
77.25%
|
404.68%
|
813.41%
|
23.33%
|
129.18%
|
98.48%
|
106.89%
|
110.81%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-11-21
|
20-11-19
|
21-11-18
|
22-11-17
|
23-11-20
|
-
|
-
|
-
|
Fiscal Period: September |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
340
|
306.5
|
315.2
|
370.6
|
379.2
|
362.7
|
385.6
|
445.9
|
472.6
|
430.4
|
466.9
|
501
|
521.5
|
473.3
|
518.6
|
EBITDA
1 |
60.5
|
59.8
|
50.9
|
80.8
|
79.9
|
84.9
|
68
|
86.9
|
98.5
|
100.5
|
83.93
|
99.71
|
103.7
|
107.3
|
92.93
|
EBIT
1 |
53.2
|
52.5
|
43.4
|
71.8
|
71.4
|
76.1
|
59.2
|
77.9
|
82.3
|
77.9
|
73.8
|
89.8
|
93.66
|
98.27
|
81.62
|
Operating Margin
|
15.65%
|
17.13%
|
13.77%
|
19.37%
|
18.83%
|
20.98%
|
15.35%
|
17.47%
|
17.41%
|
18.1%
|
15.81%
|
17.92%
|
17.96%
|
20.76%
|
15.74%
|
Earnings before Tax (EBT)
1 |
43.5
|
42.2
|
7.1
|
51.6
|
44.7
|
58.5
|
41.2
|
58.7
|
62
|
58.1
|
58.48
|
74.16
|
78.58
|
87.13
|
68.5
|
Net income
1 |
9.7
|
8.2
|
1.3
|
39.1
|
33.7
|
44.2
|
30.9
|
44.3
|
46.1
|
43.9
|
44
|
55.78
|
59.08
|
65.8
|
51.73
|
Net margin
|
2.85%
|
2.68%
|
0.41%
|
10.55%
|
8.89%
|
12.19%
|
8.01%
|
9.93%
|
9.75%
|
10.2%
|
9.42%
|
11.13%
|
11.33%
|
13.9%
|
9.97%
|
EPS
2 |
0.2500
|
0.2100
|
0.0200
|
0.2900
|
0.2500
|
0.3300
|
0.2300
|
0.3300
|
0.3500
|
0.3300
|
0.3320
|
0.4220
|
0.4480
|
0.4933
|
0.3867
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-18
|
22-02-03
|
22-05-05
|
22-08-04
|
22-11-17
|
23-02-06
|
23-05-08
|
23-08-07
|
23-11-20
|
24-02-05
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
638
|
445
|
894
|
808
|
773
|
716
|
580
|
Net Cash position
1 |
5.5
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
3.234
x
|
1.902
x
|
3.293
x
|
2.39
x
|
1.965
x
|
1.644
x
|
1.153
x
|
Free Cash Flow
1 |
95.1
|
95.1
|
225
|
19.2
|
214
|
205
|
268
|
315
|
ROE (net income / shareholders' equity)
|
26.2%
|
61.5%
|
-
|
-
|
-
|
-
|
-
|
767%
|
ROA (Net income/ Total Assets)
|
21.3%
|
25.1%
|
3.96%
|
15.5%
|
23.7%
|
29.5%
|
31.2%
|
32.4%
|
Assets
1 |
577.4
|
93.64
|
696.5
|
530.4
|
699.4
|
704.4
|
802.7
|
876.6
|
Book Value Per Share
2 |
12.30
|
-4.080
|
-0.4800
|
-2.780
|
-2.470
|
-1.950
|
-1.350
|
0.7000
|
Cash Flow per Share
2 |
2.410
|
2.460
|
5.700
|
0.2200
|
1.610
|
1.320
|
1.910
|
-
|
Capex
1 |
3.2
|
2.1
|
1.6
|
1.8
|
1.8
|
2
|
2
|
2
|
Capex / Sales
|
0.37%
|
0.21%
|
0.13%
|
0.13%
|
0.11%
|
0.1%
|
0.09%
|
0.08%
|
Announcement Date
|
19-11-21
|
20-11-19
|
21-11-18
|
22-11-17
|
23-11-20
|
-
|
-
|
-
|
Last Close Price
57.42
USD Average target price
61.8
USD Spread / Average Target +7.63% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.16% | 7.52B | | +13.21% | 8.15B | | +12.30% | 6.65B | | -5.71% | 3.73B | | -6.99% | 3.72B | | -4.78% | 1.31B | | +12.61% | 972M | | -37.22% | 958M | | -15.02% | 876M | | -18.47% | 783M |
Special Foods & Wellbeing Products
|